Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 1Inflammation 1Hypertension 1

Interventions

relacorilant 4Hydrochlorothiazide 4Nutrition Assessment 3Labetalol 2Bevacizumab 2Angiotensin-Converting Enzyme Inhibitors 2Amlodipine 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1aliskiren 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypertension × Tumor Necrosis Factors × Clear all
NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed
10 enrolled

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡